Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study

Fig. 1

Kaplan-Meier curves of cumulative incidence of total cardiovascular events (CVEs, left panels A and B) and of all-cause mortality (right panels C and D) in 400 patients with nonalcoholic fatty liver disease and type 2 diabetes divided according to having or not advanced liver fibrosis (liver stiffness measurement [LSM] > 9.6 kPa, top panels A and C) and severe steatosis (controlled attenuation parameter [CAP] > 296 dB/m, bottom panels B and D) on hepatic transient elastography

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840